ropeginterferon, welcome to the us
Published 7 years ago • 1.9K plays • Length 15:06Download video MP4
Download video MP3
Similar videos
-
12:24
development of long-acting interferon as new therapy for pv and et
-
17:02
indication for cytoreductive therapy in et and pv: do we have it right?
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
9:43
polycythemia vera: when to move from hydroxyurea to second-line therapy
-
13:09
long-acting interferon: what is the difference?
-
5:17
determining the potential of ropeginterferon alfa-2b in polycythemia vera
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
2:40
safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis
-
39:13
telfer b. reynolds lecture: hepatorenal syndrome management
-
6:34
medication video: interferon alfa 2b (intron a)
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
16:41
ropeginterferon alfa-2b for the treatment of low-risk patients with polycythemia vera
-
2:42
t2evolve introduction video
-
22:00
update on long-acting interferons for mpn
-
9:56
discover how besremi® (ropeginterferon alfa-2b-njft) works to target the source
-
3:15
what is the news about ropeginterferon?
-
21:29
topical challenges in the management of et
-
3:02
pilot study of ropeginterferon in early myelofibrosis
-
3:00
ropeginterferon alpha-2b as an effective treatment against pv
-
22:39
besremi (ropeginterferon alfa-2b-njft) injection for polycythemia vera (pv)
-
3:15
updates on ropeginterferon in pv
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b